Insights

Gene Therapy Focus MeiraGTx specializes in gene therapy with advanced capabilities in discovery, development, and manufacturing, presenting opportunities for partnerships or collaborations in the gene therapy sector.

Innovative Technology The development of riboswitch technology by MeiraGTx allows precise control of gene expression, offering a unique selling point for potential investors or partners looking for cutting-edge genetic medicine solutions.

Recent Partnerships Recent partnerships with pharmaceutical companies like J&J and Sanofi demonstrate a strategic focus on collaborations, indicating potential avenues for co-development or commercial agreements.

Financial Support With strategic investments and funding totaling $30 million, MeiraGTx showcases financial stability, making it an attractive prospect for investors or companies seeking financially backed partnerships.

Clinical Pipeline Strength MeiraGTx currently has 6 clinical programs, including one in a pivotal study, implying a robust pipeline that could present opportunities for licensing deals or product co-development.

MeiraGTx Tech Stack

MeiraGTx uses 8 technology products and services including Cloudflare, Microsoft Excel, Microsoft 365, and more. Explore MeiraGTx's tech stack below.

  • Cloudflare
    Content Management System
  • Microsoft Excel
    Editors
  • Microsoft 365
    Email
  • Backbone.js
    Javascript Frameworks
  • Windows Server
    Operating Systems
  • Microsoft Teams
    Team Collaboration
  • Animate.css
    UI Frameworks
  • Zoom
    Web Conferencing

Media & News

MeiraGTx's Email Address Formats

MeiraGTx uses at least 1 format(s):
MeiraGTx Email FormatsExamplePercentage
first.last@meiragtx.comJohn.Doe@meiragtx.com
77%
first@meiragtx.comJohn@meiragtx.com
21%
first.l@meiragtx.comJohn.D@meiragtx.com
1%
fir.last@meiragtx.comJoh.Doe@meiragtx.com
1%

Frequently Asked Questions

Where is MeiraGTx's headquarters located?

Minus sign iconPlus sign icon
MeiraGTx's main headquarters is located at 92 Brittania Walk London/New York, N17NQ GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is MeiraGTx's phone number?

Minus sign iconPlus sign icon
You can contact MeiraGTx's main corporate office by phone at +1-646-490-9751. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MeiraGTx's stock symbol?

Minus sign iconPlus sign icon
MeiraGTx is a publicly traded company; the company's stock symbol is MGTX.

What is MeiraGTx's official website and social media links?

Minus sign iconPlus sign icon
MeiraGTx's official website is meiragtx.com and has social profiles on LinkedIn.

How much revenue does MeiraGTx generate?

Minus sign iconPlus sign icon
As of June 2024, MeiraGTx's annual revenue reached $35M.

What is MeiraGTx's SIC code NAICS code?

Minus sign iconPlus sign icon
MeiraGTx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MeiraGTx have currently?

Minus sign iconPlus sign icon
As of June 2024, MeiraGTx has approximately 398 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Medical Officer: R. Z.Chief Operating Officer: R. G.Chief Commercial Officer: H. T.. Explore MeiraGTx's employee directory with LeadIQ.

What industry does MeiraGTx belong to?

Minus sign iconPlus sign icon
MeiraGTx operates in the Biotechnology Research industry.

What technology does MeiraGTx use?

Minus sign iconPlus sign icon
MeiraGTx's tech stack includes CloudflareMicrosoft ExcelMicrosoft 365Backbone.jsWindows ServerMicrosoft TeamsAnimate.cssZoom.

What is MeiraGTx's email format?

Minus sign iconPlus sign icon
MeiraGTx's email format typically follows the pattern of . Find more MeiraGTx email formats with LeadIQ.

How much funding has MeiraGTx raised to date?

Minus sign iconPlus sign icon
As of June 2024, MeiraGTx has raised $30M in funding. The last funding round occurred on Oct 30, 2023.

When was MeiraGTx founded?

Minus sign iconPlus sign icon
MeiraGTx was founded in 2015.
MeiraGTx

MeiraGTx

Biotechnology ResearchLondon/New York, United Kingdom51-200 Employees

MeiraGTx is a gene therapy company with end-to-end capabilities in gene therapy discovery, development and GMP manufacturing.  The company currently has 6 clinical programs, including one in a pivotal study.  In addition, MeiraGTx has two wholly owned GMP manufacturing facilities, a leading proprietary manufacturing platform process, large scale GMP plasmid production as well as in-house fill and finish and QC for stability and release.  This infrastructure supports multiple clinical programs from IND through commercialization.  
MeiraGTx has also built industry-leading vectorology capabilities including optimization of all viral vector elements, with multiple discovery platforms from de-novo construction thorough AI driven in silico design.  MeiraGTx has also developed a transformative riboswitch technology that tightly controls transgene expression in response to bespoke oral small molecules.  This technology allows, for the first time, precise control of any transgene in any context based on the dose of a small molecule, which provides enormous potential for expanding the possibilities in genetic medicines today. 

Section iconCompany Overview

Headquarters
92 Brittania Walk London/New York, N17NQ GB
Phone number
+1-646-490-9751
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MGTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $30M

    MeiraGTx has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Oct 30, 2023.

  • $10M$50M

    MeiraGTx's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $30M

    MeiraGTx has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Oct 30, 2023.

  • $10M$50M

    MeiraGTx's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.